PALISADE BIO, INC.
Develops targeted oral therapies for autoimmune, inflammatory, and fibrotic diseases.
PALI | US
Overview
Corporate Details
- ISIN(s):
- US6963894026 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 7750 EL CAMINO REAL, SUITE 5200, 92009 CARLSBAD
- Website:
- https://palisadebio.com/
- Sector:
- Manufacturing
Description
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company that develops and advances novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The company focuses on next-generation precision therapies, utilizing its phosphodiesterase-4 (PDE4) inhibitor prodrug platform. This platform is engineered to enable the targeted, oral delivery of therapeutics specifically to the gastrointestinal tract, aiming to enhance efficacy at the disease site while minimizing systemic side effects. Its lead development candidate, PALI-2108, is an oral PDE4 inhibitor prodrug being investigated for the treatment of inflammatory bowel diseases like ulcerative colitis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PALISADE BIO, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PALISADE BIO, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PALISADE BIO, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
